SpyGlass Pharma, Inc. Common Stock enterprise value

The Enterprise Value as of November 2026 (TTM) for SpyGlass Pharma, Inc. Common Stock (SGP) is 857.86M

According to SpyGlass Pharma, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 857.86M. This represents a change of 44.81% compared to the average of 592.40M of the last 4 quarters.

SpyGlass Pharma, Inc. Common Stock (SGP) Historical Enterprise Value (quarterly & annually)

How has SGP Enterprise Value performed in the past?

The mean historical Enterprise Value of SpyGlass Pharma, Inc. Common Stock over the last ten years is 747.68M. The current 857.86M Enterprise Value has changed 14.74% with respect to the historical average. Over the past ten years (40 quarters), SGP's Enterprise Value was at its highest in in the December 2025 quarter at 787.69M. The Enterprise Value was at its lowest in in the March 2026 quarter at 279.04M.

SpyGlass Pharma, Inc. Common Stock (SGP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of SpyGlass Pharma, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SpyGlass Pharma, Inc. Common Stock (SGP) Average Enterprise Value

How has SGP Enterprise Value performed in the past?

The current Enterprise Value of SpyGlass Pharma, Inc. Common Stock (SGP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

SpyGlass Pharma, Inc. Common Stock (SGP) Enterprise Value vs. Peers

How is SGP’s Enterprise Value compared to its peers?

SpyGlass Pharma, Inc. Common Stock’s Enterprise Value is less than Glaukos Corporation (14.15B), less than Ocular Therapeutix, Inc. (931.30M), greater than RxSight, Inc. (200.54M), less than STAAR Surgical Company (1.16B), less than Bausch + Lomb Corporation (11.71B), less than Alcon Inc. (39.57B), greater than Sight Sciences, Inc. (480.87M), greater than Oculis Holding AG (400.34M), greater than EyePoint Pharmaceuticals, Inc. (-57346396.00),

Build a custom stock screener for SpyGlass Pharma, Inc. Common Stock (SGP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SpyGlass Pharma, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SpyGlass Pharma, Inc. Common Stock (SGP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SpyGlass Pharma, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.